NCT06289062 2024-11-05Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical CancerTongji HospitalPhase 2 Recruiting40 enrolled
NCT00049556 2013-06-20Gefitinib in Treating Patients With Cervical CancerNational Cancer Institute (NCI)Phase 2 Completed